Medicare
Commentary
Stop Calling Biden’s Radical Health Agenda ‘Moderate’
After a contentious primary, Joe Biden is the presumptive Democratic presidential nominee. Earlier this month, Sen. Bernie Sanders has finally endorsed Biden, and the rest of the party is falling in line. Biden largely succeeded by positioning himself as a middle-of-the-road alternative to Sen. Sanders and his brand of democratic socialism. But Biden’s ...
Sally C. Pipes
April 27, 2020
Commentary
Coronavirus lockdown unleashes potential of this form of medicine
Ninety-five percent of the country is currently under a stay-at-home order, thanks to the coronavirus pandemic. So for those in need of a check-up, or a prescription refill, or a quick look at some swelling around a child’s eye, a virtual visit to the doctor may be the best option. ...
Sally C. Pipes
April 21, 2020
Blog
COVID-19 Reminds Us That Both Innovation and Affordability Are Needed
In her March 25 Forbes editorial, Sally Pipes documented how the private sector is rising to the health challenges of the coronavirus. Whether it is Moderna launching clinical trials for a COVID-19 vaccine or Gilead Sciences investigating whether one of its medicines, Remdesivir, is effective against the coronavirus, private sector ...
Wayne Winegarden
April 21, 2020
Commentary
Joe Biden is no moderate, especially on healthcare
After months of campaigning, Joe Biden has emerged as the presumptive Democratic presidential nominee. Last week, he finally secured the endorsement of his chief rival, Sen. Bernie Sanders. Biden succeeded by positioning himself as a moderate alternative to Sanders and other Democratic candidates. But Biden’s agenda is anything but moderate. Just look at his healthcare ...
Sally C. Pipes
April 20, 2020
Commentary
Slashing Red Tape Can Ease The Doctor Shortage
The coronavirus pandemic is threatening to stretch many hospitals to their breaking point. Beds are filling up with stricken patients, and public health officials are concerned about whether we’ll have enough doctors and other healthcare professionals to care for them. So they’re scrambling to roll back years’ worth of regulations ...
Sally C. Pipes
April 13, 2020
Commentary
Fighting coronavirus – billionaires, private sector deserve thanks for medical progress
Bill Gates announced on April 2 that his foundation would fund the construction of facilities to produce seven possible coronavirus vaccines. The Microsoft founder acknowledges that only two of those vaccines will likely succeed – and the foundation will thus waste billions of dollars on the failed candidates. That’s a small ...
Sally C. Pipes
April 13, 2020
Commentary
Coronavirus deregulating health care — this should continue after pandemic is beaten
In response to the coronavirus outbreak, the Centers for Medicare and Medicaid Services has rolled back regulations on hospitals and health care providers. Hospitals are no longer barred from treating COVID-19 patients in outpatient facilities. The feds are also freeing nurse practitioners, physician assistants and medical residents to provide more care on their own. ...
Sally C. Pipes
April 7, 2020
Commentary
The Medicare Bureaucracy Is Unnecessarily Putting Kidney Patients At Risk
The Centers for Disease Control and Prevention (CDC) has issued guidance for healthcare facilities in response to the COVID-19 virus including asking all U.S. healthcare facilities to “explore alternatives to face-to-face triage and visits.” The CDC has issued this recommendation to help contain the spread of the virus, protect healthcare workers from ...
Wayne Winegarden
April 6, 2020
Commentary
Telehealth should stay long after COVID-19 goes
The new coronavirus outbreak has put enormous pressure on the American health care system. In response, federal officials and private insurers have rushed to improve patient access to video consultations and other forms of virtual care. It may have taken a public health emergency to bring “telehealth” to the mainstream, ...
Sally C. Pipes
April 6, 2020
Commentary
In coronavirus battle, price controls would make it harder to develop lifesaving drugs
As scientists race to develop vaccines and treatments for COVID-19, Democrats in Congress have renewed their push for price controls on drugs designed to protect us from the respiratory disease caused by the coronavirus, along with other illnesses. The Democrats claim many Americans will only be able to afford the therapies that ...
Sally C. Pipes
March 30, 2020
Stop Calling Biden’s Radical Health Agenda ‘Moderate’
After a contentious primary, Joe Biden is the presumptive Democratic presidential nominee. Earlier this month, Sen. Bernie Sanders has finally endorsed Biden, and the rest of the party is falling in line. Biden largely succeeded by positioning himself as a middle-of-the-road alternative to Sen. Sanders and his brand of democratic socialism. But Biden’s ...
Coronavirus lockdown unleashes potential of this form of medicine
Ninety-five percent of the country is currently under a stay-at-home order, thanks to the coronavirus pandemic. So for those in need of a check-up, or a prescription refill, or a quick look at some swelling around a child’s eye, a virtual visit to the doctor may be the best option. ...
COVID-19 Reminds Us That Both Innovation and Affordability Are Needed
In her March 25 Forbes editorial, Sally Pipes documented how the private sector is rising to the health challenges of the coronavirus. Whether it is Moderna launching clinical trials for a COVID-19 vaccine or Gilead Sciences investigating whether one of its medicines, Remdesivir, is effective against the coronavirus, private sector ...
Joe Biden is no moderate, especially on healthcare
After months of campaigning, Joe Biden has emerged as the presumptive Democratic presidential nominee. Last week, he finally secured the endorsement of his chief rival, Sen. Bernie Sanders. Biden succeeded by positioning himself as a moderate alternative to Sanders and other Democratic candidates. But Biden’s agenda is anything but moderate. Just look at his healthcare ...
Slashing Red Tape Can Ease The Doctor Shortage
The coronavirus pandemic is threatening to stretch many hospitals to their breaking point. Beds are filling up with stricken patients, and public health officials are concerned about whether we’ll have enough doctors and other healthcare professionals to care for them. So they’re scrambling to roll back years’ worth of regulations ...
Fighting coronavirus – billionaires, private sector deserve thanks for medical progress
Bill Gates announced on April 2 that his foundation would fund the construction of facilities to produce seven possible coronavirus vaccines. The Microsoft founder acknowledges that only two of those vaccines will likely succeed – and the foundation will thus waste billions of dollars on the failed candidates. That’s a small ...
Coronavirus deregulating health care — this should continue after pandemic is beaten
In response to the coronavirus outbreak, the Centers for Medicare and Medicaid Services has rolled back regulations on hospitals and health care providers. Hospitals are no longer barred from treating COVID-19 patients in outpatient facilities. The feds are also freeing nurse practitioners, physician assistants and medical residents to provide more care on their own. ...
The Medicare Bureaucracy Is Unnecessarily Putting Kidney Patients At Risk
The Centers for Disease Control and Prevention (CDC) has issued guidance for healthcare facilities in response to the COVID-19 virus including asking all U.S. healthcare facilities to “explore alternatives to face-to-face triage and visits.” The CDC has issued this recommendation to help contain the spread of the virus, protect healthcare workers from ...
Telehealth should stay long after COVID-19 goes
The new coronavirus outbreak has put enormous pressure on the American health care system. In response, federal officials and private insurers have rushed to improve patient access to video consultations and other forms of virtual care. It may have taken a public health emergency to bring “telehealth” to the mainstream, ...
In coronavirus battle, price controls would make it harder to develop lifesaving drugs
As scientists race to develop vaccines and treatments for COVID-19, Democrats in Congress have renewed their push for price controls on drugs designed to protect us from the respiratory disease caused by the coronavirus, along with other illnesses. The Democrats claim many Americans will only be able to afford the therapies that ...